Li Jianhua, Gao Mei, Zhang Minwei, Liu Donglu, Li Zhan, Du Juanjuan, Hou Yinglong
Department of Critical Care Medicine, The First Affiliated Hospital of Xiamen University, Xiamen 361003, PR China.
Department of Cardiology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan 250014, PR China.
Cardiovasc J Afr. 2020;31(3):153-158. doi: 10.5830/CVJA-2019-064. Epub 2020 Mar 18.
Atrial fibrillation (AF) is an ectopic rhythm originating in the atrium. AF is the most common sustained cardiac arrhythmia in clinical practice and it is an enormous burden worldwide because of the high rates of morbidity, disability and mortality. Treatment of AF has become a hot spot in the field of cardiovascular medicine. Recently, increasing evidence and advancements in medical technology have helped us gain a better understanding of AF. As a result, management of AF has evolved in the past few years, so that we can better prevent and control AF. Current therapy for AF mainly includes drug therapy, catheter ablation, cryoballoon ablation, left atrial appendage closure and the maze procedure. The goal of this article is to update current treatment options for AF. We hope that this article will help deliver good care to AF patients based on the current state-of-the-art evidence.
心房颤动(AF)是起源于心房的异位心律。AF是临床实践中最常见的持续性心律失常,由于其高发病率、致残率和死亡率,它在全球范围内是一个巨大的负担。AF的治疗已成为心血管医学领域的一个热点。最近,越来越多的证据和医学技术的进步帮助我们更好地了解AF。因此,AF的管理在过去几年中不断发展,以便我们能够更好地预防和控制AF。目前AF的治疗主要包括药物治疗、导管消融、冷冻球囊消融、左心耳封堵和迷宫手术。本文的目的是更新AF的当前治疗选择。我们希望本文将基于当前的最新证据,帮助为AF患者提供优质护理。